When Nothing Else Works: Therapy Approved By FDA For Treatment-resistant Depression (Medical News Today)
Millions of patients with treatment-resistant clinical depression, who have struggled for years with disability and how to cope with their condition, now have an option that could help them lead more productive and successful lives. The NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy system, developed by Neuronetics, Inc.

FDA Statement Following CHPA's Announcement On Nonprescription Over-The-Counter Cough And Cold Medicines In Children (Medical News Today)
The U.S. Food and Drug Administration supports the voluntary actions by CHPA members to help prevent and reduce misuse and to better inform consumers about the safe and effective use of these products for children. The FDA continues to assess the safety and efficacy of these products and to revise its OTC monograph (list of approved ingredients and amounts) for these medicines.

After Ranbaxy, US FDA turns the heat on Actavis (Business Standard India)
The US Congressional committee, which is inquiring into the country's Food and Drug Administration s (FDA) handling of drug-marketing approvals of India s leading drug-maker Ranbaxy, has extended its probe into similar permissions given to Iceland s Actavis.